Preparation of fibrils and Quality control

The Michael J Fox Foundation Pff Standardization Consortium

Published: 2021-08-17 DOI: 10.17504/protocols.io.bwswpefe

Abstract

This is a consensus protocol developed through discussions with Laura Volpicelli-Daley, Caryl Sortwell, Kelvin Luk, Lindsey Gottler, and Virginia Lee. This protocol is intended for research purposes only, using specially-formulated monomeric alpha-synuclein protein available for purchase at Proteos, Inc as the result of efforts by The Michael J. Fox Foundation (MJFF). Each batch of the “Alpha-Synuclein Monomer Protein for Making Pre- Formed Fibrils” has undergone internal purification and quality control at Proteos in addition to external validation to confirm successful generation of pathogenic aSyn PFFs. See Reference section for methods and results from application of alpha-synuclein pre-formed fibrils (aSyn PFFs) in primary neuron cultures in vitro or in mice in vivo. This protocol is referenced in the Polinski et al 2018 paper entitled "Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents" (doi: 10.3233/JPD-171248).

Attachments

Steps

Step 1. Preparation of fibrils. (Timing ~30 min; 7 days for fibril formation)

1.

Thaw aliquot of “Alpha-Synuclein Monomer Protein for Making PreFormed Fibrils” or other recombinant aSyn monomer -80On ice.

2.

Centrifuge at 4°C for 0h 10m 0s in benchtop centrifuge at highest speed (12000x g,0h 0m 0s-15000x g,0h 0m 0s).

3.

Retain only the supernatant with a pipette, avoiding any aSyn that may have pelleted. Determine the protein concentration of the sample.

METHOD 1 (most recommended) : Measure protein by A280 on a nanodrop device. Use Beer’s law to measure concentration (ε for synuclein = voo5960 M−1 cm−1 for human synuclein and 7450 M−1 cm−1 for mouse synuclein).

METHOD 2 (less recommended) : Perform BCA protein assay on this material to determine final protein concentration. We recommend performing the assay at 3 dilutions of protein (in triplicate for each dilution) to obtain accurate measurements.

4.

Assemble the pre-formed fibrils (PFFs) in 1.5mL microcentrifuge tubes by diluting the monomeric protein into PBS for a final concentration of 5mg/mL.

Note
EXAMPLE : If the protein concentration is 25mg/mL, add 100µL protein to 400µL PBS in a 1.5mL tube. If the protein concentration is 6mg/mL (in 10millimolar (mM) Tris, 50millimolar (mM) NaCl, 7.6), add 44µL of a 40millimolar (mM) phosphate, 230millimolar (mM) NaCl solution to 156µL of the monomeric aSyn sample. This will result in a final buffer formulation of ~100millimolar (mM) NaCl, ~7.5millimolar (mM) Tris, and ~10millimolar (mM) phosphate with a pH of 7.2-7.6.NOTE : Because activity can decline over time when the PFFs undergo freeze-thaw cycles, we recommend that reactions not exceed 500µL per tube.

5.

Vortex tubes at high speed for 0h 0m 3s to mix contents.

6.

Place microcentrifuge lid lock on lid of tube to prevent opening of lid. Label and date tube.

7.

Place in orbital shaker (e.g. Eppendorf Thermomixer R) at 37°C.

Note
NOTE : It is recommended to place the entire shaker in a 37ºC incubator since most shakers do not heat the top of the tube, resulting in condensation.

8.

Shake for 168h 0m 0s at 1000rpm,0h 0m 0s. Solution should turn turbid during this period.

9.

Pipet 25µL aliquots in small tubes using gel loading pipet tips.

10.

Freeze aliquots on dry ice and store at -80°C or store aliquots at -80Room temperature.

Step 2. Quality control to verify fibril formation

11.

Thaw an aliquot at -80Room temperature and perform Thioflavin T assay toconfirm presence of amyloid fibrils:

11.1.

Dilute 1millimolar (mM) Thioflavin T stock in PBS to 25micromolar (µM) final concentration (1:40 dilution).

11.2.

Pipet 95µL of the 25micromolar (µM) Thioflavin T per well of 384 well plate.

11.3.

Pipet PFFs up and down to mix, add 2.5µL to wells with Thioflavin T.

11.4.

For controls, include 2.5µL PBS alone and 2.5µL monomeric aSyn.

11.5.

Incubate at -80Room temperature for 0h 2m 0s to 1h 0m 0s.

11.6.

Read plate (excitation 450nm, emission 50nm).

Note
The presence of amyloid-like fibrils typically result in readings that are 20-100 fold higher than samples containing monomeric protein only for the human aSyn.

12.
  1. The presence of fibrils can also be assessed by sedimentation.
12.1.

Dilute 2µL of 5mg/mL PFFs in 20µL PBS.

12.2.

Spin in ultracentrifuge (e.g. TLA-100) at 100000x g,0h 0m 0s for 0h 30m 0s at 25°C.

12.3.

Remove supernatant, dilute in 5X Laemlli buffer.

12.4.

Add 20µL PBS to pellet, pipet up and down several times until resuspended, dilute in 5X Laemlli buffer.

12.5.

Boil samples at 95°C for 0h 5m 0s.

12.6.

Run equal volumes of supernatant and pellet fractions on 15% polyacrylamide gel.

12.7.

Stain with coomassie brilliant blue to visualize bands.

Note
Properly generated PFFs should result in equal amounts of protein in the supernatant and pellet fractions or greater amounts of protein in the pellet versus the supernatant fraction. If more protein is in the supernatant versus the pellet, PFF formation has been suboptimal.

13.

Keep records of results of Thioflavin T and sedimentation assay to make batch to batch comparisons.

Note
NOTE : Thioflavin T and sedimentation assays are basic biochemical analyses to verify general fibril formation. More quality control is recommended when testing a new protocol for generating PFFs or generating PFFs for the first time in one’s lab. More quality control is also recommended before commencing a long-term in vivo study with aSyn PFFs. For examples for additional recommended quality control experiments, see the table in Page 1.

推荐阅读

Nature Protocols
Protocols IO
Current Protocols
扫码咨询